In the current study, we analyzed the non-coding sequence of the HES1 gene by direct sequencing and identified an unreported promoter region variant that showed in vitro gain-of-function effects as a homozygous variant and was strongly associated with an increased risk of CHD development, especially the severe subtype TGA. Here, HES1 is linked to coronary artery disorder.